Registry and Biorepository for IBD in Central Texas
Registry and Biorepository for the Study of Inflammatory Bowel Diseases in Central Texas
University of Texas at Austin
1,000 participants
Jun 1, 2021
OBSERVATIONAL
Conditions
Summary
This is a prospective, non-interventional registry and biorepository for patients with IBD. Longitudinal follow-up data is collected from both patients and their treating gastroenterologist during routine clinical encounters. The biorepository will consist of prospective collection of blood samples, tissue samples, and fecal samples for research purposes, while the participants are undergoing a clinically-indicated procedure (i.e. venipuncture for routine tests, IV catheter placement, and/or endoscopy). Participants may choose to provide any or all of the aforementioned information and/or samples.
Eligibility
Inclusion Criteria3
- Male or female, age 18 years or older
- Willing and able to provide written consent for participation in the registry and biorepository
- Patients with known or suspected inflammatory bowel disease
Exclusion Criteria4
- Patient is unable to comprehend and/or cooperate with study activities
- Patient is too ill to provide consent
- Coagulopathy that precludes safe biopsy of the bowel
- Comorbidity that precludes safe participation in endoscopic procedures
Interventions
THERE IS NO INTERVENTION TO THIS TRIAL. THIS IS A REGISTRY
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04617184